Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXL8XA
|
||||
Drug Name |
(3S,4R,8R,9S,10S,13S,14S,17S)-4-allyl-13-methyl-10-vinyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
|
||||
Synonyms |
CHEMBL392000
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H34O2
|
||||
Canonical SMILES |
C[C@]12CC[C@H]3[C@@H](CC=C4[C@@H](CC=C)[C@@H](O)CC[C@]34C=C)[C@@H]1CC[C@@H]2O
|
||||
InChI |
InChI=1S/C23H34O2/c1-4-6-16-18-8-7-15-17-9-10-21(25)22(17,3)13-11-19(15)23(18,5-2)14-12-20(16)24/h4-5,8,15-17,19-21,24-25H,1-2,6-7,9-14H2,3H3/t15-,16+,17-,19-,20-,21-,22-,23-/m0/s1
|
||||
InChIKey |
FFAZSAAUQAPBJT-NJRYMHDPSA-N
|
||||
Target and Pathway | |||||
Target(s) | Estrogen receptor beta | Target Info | [1587926] | ||
mRNA of androgen receptor | Target Info | [1587926] | |||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
Validated nuclear estrogen receptor beta network | |||||
Validated nuclear estrogen receptor alpha networksmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | |||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.